Jordan - 25 Covid-19 deaths, 5,047 infections recorded Wedne...| MENAFN.COM

Tuesday, 18 January 2022 11:10 GMT

Jordan - 25 Covid-19 deaths, 5,047 infections recorded Wednesday


(MENAFN- Jordan News Agency)


Amman, Dec. 1 (Petra) -- The Ministry of Health said Wednesday that it recorded 25 coronavirus deaths and 5,047 infections across the Kingdom, bringing the death toll from the pandemic to 11,633 and the caseload to 958,990.
According to the ministry's daily brief, the positivity rate for the day was at 9.84 per cent.
It said that the number of currently active cases reached 56,991 with 204 admitted to hospitals today, adding that 134 cases have been discharged. It said that the total number of confirmed cases that are now hospitalized reached 1,105.
According to the daily report, the occupancy rate of isolation beds in the northern region was 28 per cent, intensive care beds was 44 per cent and ventilators 28 per cent.
The occupancy rate of isolation beds in the central region was at 28 percent, intensive care beds 37 per cent and ventilators 17 per cent, it said.
In the southern region, the occupancy rate of isolation beds was at 12 per cent, intensive care beds 13 per cent and ventilators 10 per cent, it said.
The ministry said that 3,739 Covid-19 patients have recovered, bringing the total number of expected recoveries by the end of the 14-day isolation period to 890,366.
It also said that 51,284 PCR tests were conducted today, bringing the total number of swab tests that had been collected since the beginning of the pandemic to 12,220,357.
Some 4,142,489 received the first COVID-19 jab, while 3,754,055 received the two jabs, the brief added.
//Petra// AJ
01/12/2021 15:39:22

MENAFN01122021000117011021ID1103289598


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.